Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Gujarat Kidney IPO
Price Band
₹108.0–114.0
Issue Size
₹250.8 Cr
Lot Size
128 shares
Min Investment
₹14,592
GMP
+₹1.5 (1.32%)
Issue Price
₹114.0
Subject to Sauda
₹100
Paid only if allotted
Gujarat Kidney IPO AI Summary
- Gujarat Kidney IPO is listed on BSE, NSE in the Hospital sector.
- Price band: ₹108.0–₹114.0 per share, lot size 128 shares (min. investment ₹14,592).
- Subscription window: 22 Dec–24 Dec 2025, listing on 30 Dec 2025.
- Current GMP is +₹1.5 (1.32%), an estimated listing price of ₹116 — unofficial and can change daily.
Gujarat Kidney and Super Speciality Limited is entering the market with a focus on expanding its healthcare services in Gujarat. With a strong emphasis on renal sciences and a solid operational framework, the company aims to utilize the IPO proceeds for strategic acquisitions and growth initiatives.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Gujarat Kidney IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 24 Dec 2025 — not a current signal.
2 of 2 reviewers say Neutral
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Gujarat Kidney IPO Grey Market Premium (GMP) Today
GMP
+₹1.5
GMP %
+1.32%
Est. Listing
₹115.5
Updated: 25 Jul 2026 14:15
About the Company
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds. The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand). Services: Secondary Care Services: General and surgical treatments. Tertiary Care Services: Super speciality surgical procedures. Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff. Competitive Strengths: Pre-eminence in renal sciences, with established sub-superspecialities in urology Asset light business model with focus in central region of Gujarat Ability to attract, retain skilled and experienced quality medical professionals Track record of operating and financial performance and growth
Company Financials (₹ Cr)
As of 2025-06-30
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| NET Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 |
Key Ratios
EPS
₹1.85
NAV
₹5.04
ROE
36.61%
ROCE
37.65%
RoNW
36.61%
P/B Value
22.62
P/E Ratio
61.62
Market Cap
₹898.81 Cr
PAT Margin
23.61%
Debt/Equity
0.15
Peer Comparison
| Company | NAV | RoNW | EPS Basic | EPS Diluted | P/E (x) |
|---|---|---|---|---|---|
| Gujarat Kidney & Super Speciality Limited | 5.04 | 36.61% | 1.85 | 1.85 | — |
| Kmc Speciality Hospitals (india) Ltd | 23.16 | 13.04% | 1.31 | 9.25 | 52.6 |
| Gpt Healthcare Limited | 40.71 | 20.14% | 6.08 | 12.26 | 24.51 |
| Yatharth Hospital & Trauma Care Services Limited This IPO | 88.05 | 8.13% | 14.72 | 14.83 | 55.84 |
Promoters
Pragnesh Yashwantsinh Bharpoda, Bhartiben Pragnesh Bharpoda, Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Proposed acquisition of Parekhs Hospital at Ahmedabad. 77.00 2 Part-payment of purchase consideration for the already acquired Ashwini Medical Centre. 12.40 3 Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. 30.10 4 Buying robotics equipment for hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. 6.83 5 Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company 1.20 6 Funding inorganic growth through unidentified acquisitions and general corporate purposes. 87.44 7 Acquisition of additional shareholding in the subsidiary namely Harmony Medicare Pvt.Ltd. at Bharuch 10.78 8 Issue Expenses 25.06 Total 250.80
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹0.00 in the period ending 31 Mar 2023, increasing to ₹5.48 Cr by 31 Mar 2024. This figure rose significantly to ₹40.40 Cr by 31 Mar 2025, before dropping to ₹15.27 Cr in the most recent period ending 30 Jun 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was a loss of ₹0.01 in the period ending 31 Mar 2023, which improved to ₹1.71 Cr by 31 Mar 2024. This continued to rise to ₹9.50 Cr by 31 Mar 2025, before decreasing to ₹5.40 Cr in the most recent period ending 30 Jun 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Gujarat Kidney is priced at a P/E ratio of 61.62 at the issue price, compared to peers trading at a P/E range of 24.51 to 55.84.
Grey Market Premium, Explained
The Grey Market Premium (GMP) is an unofficial indicator of the expected listing price of an IPO. It reflects the demand for the shares before they are officially listed on the stock exchange. A positive GMP suggests that the shares might list at a premium, while a negative GMP indicates potential listing at a discount.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's growth potential and the healthcare sector's dynamics.
Who May Want to Wait
Investors who are risk-averse or prefer stable and established companies may want to avoid this IPO, as it operates in a competitive and potentially volatile healthcare sector.
IPO Timeline, Explained
The IPO opens for subscription on December 22, 2025, and closes on December 24, 2025. Allotment of shares is expected by December 26, 2025, with the listing date set for December 30, 2025.
Listing Gains — The Risk
Listing gains can be unpredictable and are influenced by market conditions, investor sentiment, and the company's performance. Investors should be aware that while some IPOs may see significant gains on the listing day, others may not perform as expected.
This evaluation is generated from Gujarat Kidney's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Gujarat Kidney IPO GMP today?
Gujarat Kidney IPO GMP today is +₹1.5 (1.32%), indicating an estimated listing price of ₹116. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Gujarat Kidney IPO?
The price band of Gujarat Kidney IPO is ₹108.0–₹114.0 per share.
When does Gujarat Kidney IPO open and close?
Gujarat Kidney IPO opens on 22 December 2025 and closes on 24 December 2025.
When does Gujarat Kidney IPO list on the stock exchange?
Gujarat Kidney IPO listed on 30 December 2025 at ₹115.5.
What is the lot size for Gujarat Kidney IPO?
The lot size for Gujarat Kidney IPO is 128 shares, requiring a minimum investment of ₹14,592.
What is the price band for the IPO?
The price band for the IPO is ₹108 to ₹114.
What is the minimum investment required?
The minimum investment required is ₹14,592.
What is the lot size for the IPO?
The lot size for the IPO is 128 shares.
When does the IPO open and close?
The IPO opens on December 22, 2025, and closes on December 24, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO based on unofficial trading.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
22 Dec 2025
Close
24 Dec 2025
Allotment
26 Dec 2025
Listing
30 Dec 2025
Similar IPOs in Hospital
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Gujarat Kidney?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.